This makes PSMA an excellent biological target for diagnosis and treatment of prostate cancer.30 A high number of PSMA-targeting radioligands are known, including the diagnostic gold standard [68Ga]Ga-PSMA-11 and the therapeutic counterpart [177Lu]Lu-PSMA-617.31 The gene discussed is FOLH1; the disease is prostate cancer.